
GC31591
LDL-IN-3
Also known as 2,6-ditert-butyl-4-[[(4-methoxyphenyl)-dimethylsilyl]methoxy]phenol
LDL-IN-3 is an anti-atherosclerotic compound extracted from patent WO/2005/039596A1, example C25 and patent US 6133467, example 3
ChemicalCAS180908-67-2MW400.63FormulaC24H36O3Si
- CAS number
- 180908-67-2
- Molecular weight
- 400.63
- Formula
- C24H36O3Si
- Solubility
- Soluble in DMSO
- InChIKey
- PJKUTMONJXDZNR-UHFFFAOYSA-N
- Catalogue number
- GC31591
- Brand
- GLPBIO
Computed properties PubChem CID 9952842 · TPSA 38.7 Ų · H-bond donors 1 · H-bond acceptors 3
- TPSA
- 38.7 Ų
- H-bond donors
- 1
- H-bond acceptors
- 3
- Rotatable bonds
- 7
- Heavy atoms
- 28
SMILES CC(C)(C)C1=CC(=CC(=C1O)C(C)(C)C)OC[Si](C)(C)C2=CC=C(C=C2)OC
Computed descriptors from PubChem (CID 9952842), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.
Ordering in Israel
- Lead time
- Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
- Pricing
- Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
- Documents
- Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
- Who we serve
- Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.
- Questions
- WhatsApp · +972-55-990-7576 · orders@labo.co.il